139 related articles for article (PubMed ID: 15577585)
21. Radioiodine and percutaneous ethanol injection in the treatment of large toxic thyroid nodule: a long-term study.
Zingrillo M; Torlontano M; Ghiggi MR; Frusciante V; Varraso A; Liuzzi A; Trischitta V
Thyroid; 2000 Nov; 10(11):985-9. PubMed ID: 11128727
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and management of the autonomously functioning thyroid nodule: the Walter Reed Army Medical Center experience, 1975-1996.
Burch HB; Shakir F; Fitzsimmons TR; Jaques DP; Shriver CD
Thyroid; 1998 Oct; 8(10):871-80. PubMed ID: 9827653
[TBL] [Abstract][Full Text] [Related]
23. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET.
Eschmann SM; Reischl G; Bilger K; Kupferschläger J; Thelen MH; Dohmen BM; Besenfelder H; Bares R
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):760-7. PubMed ID: 12029549
[TBL] [Abstract][Full Text] [Related]
25. [Changes in thyroid volume after radioactive iodine therapy in patients with single toxic thyroid nodule].
Gołkowski F; Jabrocka-Hybel A; Huszno B
Przegl Lek; 2005; 62(5):284-6. PubMed ID: 16334533
[TBL] [Abstract][Full Text] [Related]
26. [Therapeutic efficiency of iodine 131 in autonomous thyroid adenoma and toxic multinodular goiter. Apropos of 59 cases].
Guermazi F; Fekih MA; Kraiem A; Mtimet S
Ann Endocrinol (Paris); 1991; 52(5):323-6. PubMed ID: 1819221
[TBL] [Abstract][Full Text] [Related]
27. Treatment of autonomously functioning thyroid nodules at a single institution: radioiodine therapy, surgery, and ethanol injection therapy.
Yano Y; Sugino K; Akaishi J; Uruno T; Okuwa K; Shibuya H; Kitagawa W; Nagahama M; Ito K; Ito K
Ann Nucl Med; 2011 Dec; 25(10):749-54. PubMed ID: 21971604
[TBL] [Abstract][Full Text] [Related]
28. [Radiometabolic therapy of the autonomous thyroid nodule].
Mariotti S; Caturegli P; Barbesino G; Ceccarelli C; Lippi F; Marinò M; Manetti L; Martino E; Pinchera A
Minerva Endocrinol; 1993 Dec; 18(4):155-63. PubMed ID: 8190055
[TBL] [Abstract][Full Text] [Related]
29. Ultrasonographic thyroid volume as a reliable prognostic index of radioiodine-131 treatment outcome in Graves' disease hyperthyroidism.
Gómez-Arnaiz N; Andía E; Gumà A; Abós R; Soler J; Gómez JM
Horm Metab Res; 2003 Aug; 35(8):492-7. PubMed ID: 12953167
[TBL] [Abstract][Full Text] [Related]
30. Standard dose 131I therapy for toxic multinodular goiter in an endemic goiter region.
Gonçalves E; Castro JA; Gross JL
Braz J Med Biol Res; 1986; 19(6):723-9. PubMed ID: 3651625
[TBL] [Abstract][Full Text] [Related]
31. Iodine-131 therapy for hyperthyroidism prescribed by endocrinologist - our preliminary experience.
Leow MK; Loh KC; Zhu M; Chan SP; Sundram FX
Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):616-21. PubMed ID: 19053029
[TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up of treatment of thyrotoxicosis by three different methods.
Franklyn JA; Daykin J; Drolc Z; Farmer M; Sheppard MC
Clin Endocrinol (Oxf); 1991 Jan; 34(1):71-6. PubMed ID: 2004475
[TBL] [Abstract][Full Text] [Related]
33. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study.
Ceccarelli C; Bencivelli W; Vitti P; Grasso L; Pinchera A
Clin Endocrinol (Oxf); 2005 Mar; 62(3):331-5. PubMed ID: 15730415
[TBL] [Abstract][Full Text] [Related]
34. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
35. Is standard 555 MBq 131I-therapy of hyperthyroidism ablative?
Bertelsen J; Herskind AM; Sprogøe Jakobsen U; Hegedüs L
Thyroidology; 1992 Dec; 4(3):103-6. PubMed ID: 1285034
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
Listewnik MH
Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
[TBL] [Abstract][Full Text] [Related]
37. Changes in the thyroid technetium-99m scintigram after antithyroid and subsequent radioiodine treatment for solitary autonomous nodules.
Nygaard B
Thyroid; 1998 Mar; 8(3):223-7. PubMed ID: 9545108
[TBL] [Abstract][Full Text] [Related]
38. Predictors of Hypothyroidism Following Empirical Dose Radioiodine in Toxic Thyroid Nodules: Real-Life Experience.
Demir BK; Karakilic E; Saygili ES; Araci N; Ozdemir S
Endocr Pract; 2022 Aug; 28(8):749-753. PubMed ID: 35537668
[TBL] [Abstract][Full Text] [Related]
39. Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake.
Reinhardt MJ; Joe A; von Mallek D; Zimmerlin M; Manka-Waluch A; Palmedo H; Krause TM
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):480-5. PubMed ID: 11914885
[TBL] [Abstract][Full Text] [Related]
40. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
